INKON Life Technology Co., Ltd.

XSEC:300143 Stock Report

Market Cap: CN¥6.4b

INKON Life Technology Past Earnings Performance

Past criteria checks 3/6

INKON Life Technology has been growing earnings at an average annual rate of 14.6%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 18% per year. INKON Life Technology's return on equity is 6.1%, and it has net margins of 5.6%.

Key information

14.6%

Earnings growth rate

16.1%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate18.0%
Return on equity6.1%
Net Margin5.6%
Next Earnings Update29 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How INKON Life Technology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSEC:300143 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,5958923647
30 Jun 241,5708524050
31 Mar 241,5268723253
31 Dec 231,47110022452
30 Sep 231,396-55721057
30 Jun 231,305-57320046
31 Mar 231,250-58019936
01 Jan 231,156-59617028
30 Sep 221,106-43617221
30 Jun 221,129-35816725
31 Mar 221,116-35815928
01 Jan 221,090-36416529
30 Sep 211,38823317726
30 Jun 211,28116316621
31 Mar 211,17017916718
31 Dec 201,02914915717
30 Sep 20659-70013019
30 Jun 20602-70014317
31 Mar 20567-71613214
31 Dec 19573-70312911
30 Sep 19520211208
30 Jun 19508281028
31 Mar 19467151008
31 Dec 1850450977
30 Sep 1847164934
30 Jun 1845187819
31 Mar 18433107828
31 Dec 17329122697
30 Sep 17381150696
30 Jun 17388122810
31 Mar 1739098780
31 Dec 1643255910
30 Sep 1637732920
30 Jun 1632918830
31 Mar 1629017730
31 Dec 1528011670
30 Sep 15289-253790
30 Jun 15297-272840
31 Mar 15300-294870
31 Dec 14308-293880
30 Sep 14297-135830
30 Jun 14287-132850
31 Mar 14274-147880

Quality Earnings: 300143 has high quality earnings.

Growing Profit Margin: 300143 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 300143 has become profitable over the past 5 years, growing earnings by 14.6% per year.

Accelerating Growth: 300143 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 300143 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).

Return on Equity

High ROE: 300143's Return on Equity (6.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 12:45
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

INKON Life Technology Co., Ltd. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
YANG QIAOChangjiang Securities Co. LTD.
Junqi HuangChina Merchants Securities Co. Ltd.
Dahui ZhaoChina Minzu Securities